Japan, Jan. 28 -- CCOA THERAPEUTICS (HANGZHOU) CO LTD has got intellectual property rights for 'HUMANIZED ANTI-GLYCOPROTEIN IB ALPHA (GPIBALPHA) ANTIBODY.' Other related details are as follows:
Application Number: JP,2024-103442
Category (FI): A61P35/04,A61P7/02,A61P9/10,A61K39/395@T,C12N15/13,C07K16/46,A61K39/395@N,C07K16/28,C07K19/00,A61P9/00,C12P21/08
Stage: Grant (IP right document published.)
Filing Date: June 27, 2024
Publication Date: Sept. 10, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....